Bayer raises 2026 adjusted EBITDA outlook to EUR 9.8 billion-10.3 billion at constant currencies

By Public Technologies
  • Bayer raised its 2026 constant-currency adjusted EBITDA forecast to 9.8 billion–10.3 billion euros, from 9.6 billion–10.1 billion euros.
  • Free cash flow is now forecast at negative 1.5 billion–negative 0.5 billion euros, an improvement of 1 billion euros.
  • Year-end net financial debt is projected at 28 billion–29 billion euros at constant currencies, versus 29 billion–30 billion euros previously.
  • The pharmaceutical adjusted EBITDA margin outlook increased to 25%–27% from 24%–26%, supported by strong performance.
  • Nine-month adjusted EBITDA grew 7%, while organic sales rose 3%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bayer AG published the original content used to generate this news brief on November 03, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
 

Cryptocurrency-related content is intended solely as news and market commentary. Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.